TW_Research1/8/21, 01:33 PM$TFFP connect the dots with this PR y'all. It's potentially highly significant for our monster in the making here. prnewswire.com/news-release...Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset targeting P. aeruginosa infectionsvia: Prnewswire1412214 Likes
Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset targeting P. aeruginosa infectionsvia: Prnewswire